Portal Biotechnologies
PrivateLast Round
Series A
Jun 30, 2025
Total Funding Raised
$35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Portal Biotechnologies is a cell engineering platform company that provides mechanical intracellular delivery technology for drug discovery, AI data generation, and cell therapy applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Portal Biotechnologies Comparables
Compare Portal Biotechnologies with similar companies based on industry and business-model similarity.
Portal Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 30, 2025 |
Key People
Founding team and executive leadership
Portal Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCVC | Series A |
| British Business Bank | Series A |
| Amino Collective | Series A |
| NATO Innovation Fund | Series A |
| Pillar VC | Series A |
| Earlybird Venture Capital | Series A |
| 8VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 18% QoQ, from 60 to 71 employees.
- Jul 26, 2026
Monthly visitors grew 56% MoM.
Portal Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Portal Biotechnologies's valuation, stock price, and market status.
Is Portal Biotechnologies a public or private company?
Portal Biotechnologies is a private company.
What is the current stock price of Portal Biotechnologies?
Portal Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is Portal Biotechnologies worth (valuation)?
Valuation information for Portal Biotechnologies is not publicly available.
Can I buy Portal Biotechnologies stock?
Portal Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Portal Biotechnologies's last funding round?
Portal Biotechnologies's most recent funding round was Series A on June 30, 2025.
Who are the main investors in Portal Biotechnologies?
Key investors in Portal Biotechnologies include NATO Innovation Fund, Earlybird Venture Capital.
Will Portal Biotechnologies IPO soon?
No public IPO plans have been announced for Portal Biotechnologies.
How can I track Portal Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Portal Biotechnologies's secondary market activity and sign up for updates.